Company intelligence / Profile preview

BioRewards Plasma Services

Scottsdale, Arizona, United Statesbusinesswire.com ↗

Ownership: Private
Development stage: Commercial

Overview

Recently launched with $100M+ in funding to open over 20 state-of-the-art U.S. plasma collection centers within three years. Focuses on high-quality source and hyperimmune plasma supply for global pharmaceutical fractionators. Leverages advanced digital technologies to optimize donor experience and operational efficiency.

Therapeutic areas: ImmunologyHematology
Modalities: Source plasmaHyperimmune plasma
Industry: Chemicals & Materials

Partnerships

Strategic partnerships with global PDMP fractionators (undisclosed names)

Beyond the preview

Go deeper on BioRewards Plasma Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioRewards Plasma Services.

Explore the full profile